UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Clinical manifestations and diagnosis of surgical aortic and mitral prosthetic valve regurgitation

Authors
Alvaro Marco del Castillo, MD
Pepe Zamorano, MD
Section Editor
Patrizio Lancellotti, MD, PhD, FESC, FACC
Deputy Editor
Susan B Yeon, MD, JD, FACC

INTRODUCTION

Prosthetic valve dysfunction encompasses prosthetic valve obstruction (stenosis) and prosthetic valve regurgitation. Regurgitation associated with prosthetic heart valves includes regurgitation through the valve (transvalvular) as well as paravalvular regurgitation (also known as paravalvular leak). Symptomatic severe prosthetic valve regurgitation is an uncommon complication of surgical valve replacement. However, it is associated with poor outcomes with both conservative management and surgical treatment.

This topic will discuss clinical manifestations and diagnosis of surgical prosthetic aortic and mitral valve regurgitation. Transcatheter heart valve regurgitation and prognosis and management of surgical prosthetic valve regurgitation are discussed separately. (See "Transcatheter aortic valve implantation: Complications" and "Management and prognosis of surgical aortic and mitral prosthetic valve regurgitation".)

DEFINITIONS AND PREVALENCE

Normally functioning mechanical valves and some normally functioning bioprosthetic valves have trivial to mild transvalvular regurgitation, which should be distinguished from pathological regurgitation. On color Doppler echocardiographic imaging of normally functioning mechanical prosthetic valves, two types of retrograde jets are seen: a closing volume caused by motion of the occluder and true trivial or mild regurgitation at the edges of the occluder. Mechanical prosthetic valves are designed to cause trivial to mild transvalvular regurgitation when functioning normally as a safety mechanism known as leakage backflow or washing jets; this mechanism is thought to reduce the risk of valve thrombosis. Trivial regurgitation is also normal for some types of bioprosthetic valves (particularly stentless valves), due to minimal leaflet retraction once placed.

The principal types of pathologic prosthetic valve regurgitation are transvalvular regurgitation (due to structural valve deterioration or non-structural valve dysfunction) and paravalvular leakage:

Transvalvular regurgitation − Pathologic transvalvular regurgitation is much more common with bioprosthetic valves compared with mechanical valves. With conventional stented bioprostheses, 10 to 30 percent had significant structural valve deterioration at 10 years, and 20 to 50 percent at 15 years [1]. However, structural valve deterioration includes both regurgitation and stenosis, and the prevalence of patients with regurgitation is unknown. The rate of structural failure decreases with age, probably in part due to less activity in older patients.

                             

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2017. | This topic last updated: Jul 03, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Hammermeister K, Sethi GK, Henderson WG, et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 2000; 36:1152.
  2. Bourguignon T, Bouquiaux-Stablo AL, Candolfi P, et al. Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position. Ann Thorac Surg 2015; 99:831.
  3. Ionescu A, Fraser AG, Butchart EG. Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography. Heart 2003; 89:1316.
  4. Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J 1999; 138:351.
  5. Pate GE, Al Zubaidi A, Chandavimol M, et al. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv 2006; 68:528.
  6. Ruiz CE, Jelnin V, Kronzon I, et al. Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks. J Am Coll Cardiol 2011; 58:2210.
  7. Chen YT, Kan MN, Chen JS, et al. Detection of prosthetic mitral valve leak: a comparative study using transesophageal echocardiography, transthoracic echocardiography, and auscultation. J Clin Ultrasound 1990; 18:557.
  8. Skoularigis J, Essop MR, Skudicky D, et al. Frequency and severity of intravascular hemolysis after left-sided cardiac valve replacement with Medtronic Hall and St. Jude Medical prostheses, and influence of prosthetic type, position, size and number. Am J Cardiol 1993; 71:587.
  9. Shapira Y, Bairey O, Vatury M, et al. Erythropoietin can obviate the need for repeated heart valve replacement in high-risk patients with severe mechanical hemolytic anemia: case reports and literature review. J Heart Valve Dis 2001; 10:431.
  10. Zoghbi WA, Chambers JB, Dumesnil JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009; 22:975.
  11. O'Rourke DJ, Palac RT, Malenka DJ, et al. Outcome of mild periprosthetic regurgitation detected by intraoperative transesophageal echocardiography. J Am Coll Cardiol 2001; 38:163.
  12. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 2009; 119:1034.
  13. Lancellotti P, Pibarot P, Chambers J, et al. Recommendations for the imaging assessment of prosthetic heart valves: a report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2016; 17:589.
  14. Kumar R, Jelnin V, Kliger C, Ruiz CE. Percutaneous paravalvular leak closure. Cardiol Clin 2013; 31:431.
  15. Kronzon I, Sugeng L, Perk G, et al. Real-time 3-dimensional transesophageal echocardiography in the evaluation of post-operative mitral annuloplasty ring and prosthetic valve dehiscence. J Am Coll Cardiol 2009; 53:1543.
  16. De Cicco G, Lorusso R, Colli A, et al. Aortic valve periprosthetic leakage: anatomic observations and surgical results. Ann Thorac Surg 2005; 79:1480.
  17. Bach DS. Transesophageal echocardiographic (TEE) evaluation of prosthetic valves. Cardiol Clin 2000; 18:751.
  18. Lázaro C, Hinojar R, Zamorano JL. Cardiac imaging in prosthetic paravalvular leaks. Cardiovasc Diagn Ther 2014; 4:307.
  19. Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J 2011; 32:2189.
  20. De Cicco G, Russo C, Moreo A, et al. Mitral valve periprosthetic leakage: Anatomical observations in 135 patients from a multicentre study. Eur J Cardiothorac Surg 2006; 30:887.
  21. Saeed O, Williams BR Jr, Ku M, Lattouf OM. Bioprosthetic mitral valve thrombosis less than one year after replacement and an ablative MAZE procedure: a case report. J Cardiothorac Surg 2010; 5:18.
  22. Jung Y, Ahn BH, Lee KS, et al. A novel solution to prosthetic valve dehiscence after aortic valve surgery in Behçet's disease. Interact Cardiovasc Thorac Surg 2017; 24:342.
  23. García-Fernández MA, Cortés M, García-Robles JA, et al. Utility of real-time three-dimensional transesophageal echocardiography in evaluating the success of percutaneous transcatheter closure of mitral paravalvular leaks. J Am Soc Echocardiogr 2010; 23:26.
  24. Pflaumer A, Schwaiger M, Hess J, et al. Quantification of periprosthetic valve leakage with multiple regurgitation jets by magnetic resonance imaging. Pediatr Cardiol 2005; 26:593.
  25. Jelnin V, Co J, Muneer B, et al. Three dimensional CT angiography for patients with congenital heart disease: scanning protocol for pediatric patients. Catheter Cardiovasc Interv 2006; 67:120.
  26. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129:2440.
  27. Taylor J. ESC/EACTS Guidelines on the management of valvular heart disease. Eur Heart J 2012; 33:2371.